The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.

@article{Bergh2008ThePC,
  title={The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.},
  author={Roderick C. N. van den Bergh and Monique J Roobol and Tineke Wolters and Pim J van Leeuwen and Fritz H. Schroeder},
  journal={BJU international},
  year={2008},
  volume={102 9},
  pages={1068-73}
}
OBJECTIVE To assess the potential problem that different tools for predicting a positive outcome of prostate biopsy can produce divergent outcomes in the same man, by comparing the risk calculators based on the Prostate Cancer Prevention Trial (PCPT) and the European Randomized Study of Screening for Prostate Cancer (ERSPC). MATERIALS AND METHODS In the prostate-specific antigen (PSA) range of 0.2-30.0 ng/mL, the prediction curves of 'virtual' standard study participants were evaluated using… CONTINUE READING